Compare AstraZeneca plc (AZN) vs LTC Properties Inc (LTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs LTC Properties Inc — how do they compare? AstraZeneca plc trades at $157.99 (market cap $248.14B), while LTC Properties Inc trades at $38.12 (market cap $2.05B). The key difference: AstraZeneca plc is far larger — about 121× LTC Properties Inc's market cap, and LTC Properties Inc pays the higher dividend (5.98%). Which is the better fit depends on your goals.
| AZN | LTC | |
|---|---|---|
Market Cap | $248.14B | $2.05B |
Sector | Health | Real Estate |
52-Week High | $209.48 | $42.81 |
52-Week Low | $147.06 | $33.98 |
Enterprise Value | $275.41B | $2.79B |
Dividend Yield | 2.01% | 5.98% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About LTC Properties Inc
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →
